Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zine-Eddine Khene

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|June 11, 2024
An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancerZine-Eddine Khene, Yair Lotan
European Urology|January 7, 2023
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 TrialZine-Eddine Khene, Delphine Borchiellini, Karim Bensalah
BJU International|April 3, 2023
Machine learning in renal cell carcinoma research: the promise and pitfalls of 'renal-izing' the potential of artificial intelligenceZine-Eddine Khene, Alexander Kutikov, Riccardo Campi, et al.
European Urology|May 1, 2020
Re: Pathologic Response and Surgical Outcomes in Patients Undergoing Nephrectomy Following Receipt of Immune Checkpoint Inhibitors for Renal Cell CarcinomaZine-Eddine Khene, Géraldine Pignot, Karim Bensalah
European Urology|November 20, 2021
Adjuvant Therapy After Surgical Resection of Nonmetastatic Renal Cell Carcinoma: One Size Does Not Fit AllZine-Eddine Khene, Axel Bex, Karim Bensalah
European Urology|January 31, 2022
Re: Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau DiseaseKarim Bensalah, Zine-Eddine Khene, Christophe Massard
Urologia Internationalis|June 4, 2023
Adjustable Continence Therapy Balloons in Female Patients with Stress Urinary Incontinence: A Systematic ReviewSonia Guérin, Zine-Eddine Khene, Benoit Peyronnet
European Urology|December 4, 2025
Artificial Intelligence for Risk Prediction in Non-muscle-invasive Bladder Cancer: From Complexity to Clinical ClarityZine-Eddine Khene, Karim Bensalah, Morgan Rouprêt
Current Opinion in Urology|October 24, 2024
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancerRaj R Bhanvadia, Zine-Eddine Khene, Vitaly Margulis
European Urology Oncology|May 18, 2019
Robot-assisted Versus Open Partial Nephrectomy: Do We Really Need More Evidence To End the Debate?Benoit Peyronnet, Zine-Eddine Khene, Romain Mathieu, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|June 11, 2024
An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancerZine-Eddine Khene, Yair Lotan
European Urology|January 7, 2023
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 TrialZine-Eddine Khene, Delphine Borchiellini, Karim Bensalah
BJU International|April 3, 2023
Machine learning in renal cell carcinoma research: the promise and pitfalls of 'renal-izing' the potential of artificial intelligenceZine-Eddine Khene, Alexander Kutikov, Riccardo Campi, et al.
European Urology|May 1, 2020
Re: Pathologic Response and Surgical Outcomes in Patients Undergoing Nephrectomy Following Receipt of Immune Checkpoint Inhibitors for Renal Cell CarcinomaZine-Eddine Khene, Géraldine Pignot, Karim Bensalah
European Urology|November 20, 2021
Adjuvant Therapy After Surgical Resection of Nonmetastatic Renal Cell Carcinoma: One Size Does Not Fit AllZine-Eddine Khene, Axel Bex, Karim Bensalah
European Urology|January 31, 2022
Re: Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau DiseaseKarim Bensalah, Zine-Eddine Khene, Christophe Massard
Urologia Internationalis|June 4, 2023
Adjustable Continence Therapy Balloons in Female Patients with Stress Urinary Incontinence: A Systematic ReviewSonia Guérin, Zine-Eddine Khene, Benoit Peyronnet
European Urology|December 4, 2025
Artificial Intelligence for Risk Prediction in Non-muscle-invasive Bladder Cancer: From Complexity to Clinical ClarityZine-Eddine Khene, Karim Bensalah, Morgan Rouprêt
Current Opinion in Urology|October 24, 2024
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancerRaj R Bhanvadia, Zine-Eddine Khene, Vitaly Margulis
European Urology Oncology|May 18, 2019
Robot-assisted Versus Open Partial Nephrectomy: Do We Really Need More Evidence To End the Debate?Benoit Peyronnet, Zine-Eddine Khene, Romain Mathieu, et al.
Pageof 13